Insider Transactions in Q4 2021 at Immunity Bio, Inc. (IBRX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2021
|
David C. Sachs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,242
+28.29%
|
-
|
|
Oct 08
2021
|
Richard Adcock CEO & President |
BUY
Open market or private purchase
|
Indirect |
1,930
+49.95%
|
$15,440
$8.9 P/Share
|